| Financial Year |
March 31 2023 |
| Monetary Funds |
169,897,990.13 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
50,905,069.89 |
| Accounts Receivable |
326,802,688.34 |
| Advances to Suppliers |
33,351,550.38 |
| Other Receivables |
4,859,953.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
254,270,511.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
991,321.15 |
| Total Current Assets |
985,233,433.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
474,895,225.05 |
| Under-construction Projects |
343,760,872.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
98,719,089.52 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
21,055,426.44 |
| Other Non-Current Assets |
83,773,469.20 |
| Sub-Total of Non-Current Assets |
1,022,904,082.82 |
| Total Assets |
2,008,137,515.92 |
| Short-Term Loans |
352,325,479.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
125,937,285.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,990,948.44 |
| Taxes Payable |
11,949,963.82 |
| Interest Payable |
1,520,029.99 |
| Dividend Payable |
-- |
| Other payables |
62,918,179.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
115,400,000.00 |
| Other Current Liabilities |
1,480,884.29 |
| Sub-Total of Current Liabilities |
693,928,165.57 |
| Long-term Loans |
57,000,000.00 |
| Bonds Payable |
295,004,058.82 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
360,206,405.57 |
| Total Liabilities |
1,054,134,571.14 |
| Paid-In Capital(Or Share Stock) |
232,325,005.00 |
| Capital Surplus |
76,536,397.67 |
| Surplus Reserve |
60,952,213.12 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
509,092,487.77 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
954,002,944.78 |
| Owner's Equity（Stockholder's Equity） |
954,002,944.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,008,137,515.92 |
